Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-15 4:45 pm Sale | 2021-03-15 | 13D | Marker Therapeutics, Inc. MRKR | Eastern Capital LTD | 396,667 5.000% | -50,000 (-11.19%) | Filing History |
| 2021-02-19 5:02 pm Sale | 2021-02-18 | 13G | Cytokinetics, Incorporated CYTK | Eastern Capital LTD | 3,062,748 4.300% | -544,781 (-15.10%) | Filing History |
| 2021-01-26 4:19 pm Purchase | 2021-01-25 | 13G | Avid Bioservices, Inc. CDMO | Eastern Capital LTD | 523,810 0.900% | 523,810 (New Position) | Filing History |
| 2020-11-13 4:14 pm Sale | 2020-11-09 | 13D | Marker Therapeutics, Inc. MRKR | Eastern Capital LTD | 446,667 9.200% | -41,667 (-8.53%) | Filing History |
| 2020-08-13 4:54 pm Sale | 2020-08-12 | 13D | iBio, Inc. IBIO | Eastern Capital LTD | 2,000 0.600% | -15,259 (-88.41%) | Filing History |
| 2020-08-11 5:04 pm Sale | 2020-08-10 | 13D | iBio, Inc. IBIO | Eastern Capital LTD | 17,259 5.800% | -48,970 (-73.94%) | Filing History |
| 2020-08-07 10:14 am Unchanged | 2020-08-07 | 13D | iBio, Inc. IBIO | Eastern Capital LTD | 66,229 22.300% | 0 (Unchanged) | Filing History |
| 2020-08-06 5:22 pm Sale | 2020-08-04 | 13D | iBio, Inc. IBIO | Eastern Capital LTD | 66,229 22.300% | -8,536 (-11.42%) | Filing History |
| 2020-06-18 4:42 pm Sale | 2020-06-16 | 13D | Marker Therapeutics, Inc. MRKR | Eastern Capital LTD | 488,334 10.300% | -41,667 (-7.86%) | Filing History |
| 2020-05-05 5:23 pm Purchase | 2020-04-24 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Eastern Capital LTD | 7,224 3.900% | 7,224 (New Position) | Filing History |